Promising New Treatment Minimizes Negative Side Effects of Chemotherapy for Small Cell Lung Cancer Patients

Research conducted by Florida Cancer Specialists & Research Institute, LLC recently confirmed the effectiveness of a new medication in protecting bone marrow of patients who receive chemotherapy for extensive-stage small cell lung cancer.

Related Keywords

Florida ,United States ,Lowell Hart ,Florida Cancer Specialists Research Institute ,Us Food Drug Administration ,Florida Cancer Specialists ,Research Institute ,Villages Daily ,Drug Administration ,Trilaciclib Effectiveness ,Fcs ,Trilaciclib ,Nsclc ,Lung Cancer ,Real World Outcomes ,Advances In Therapy ,Small Cell Lung Cancer ,Extensive Stage Small Cell Lung Cancer ,